γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer

Cancer is a leading cause of death worldwide and the prognostic evaluation of cancer patients is of great importance in medical care. The use of artificial neural networks in prediction problems is well established in human medical literature. The aim of the current study was to assess the prognosti...

Full description

Bibliographic Details
Main Authors: E. Chatzimichail, D. Matthaios, D. Bouros, P. Karakitsos, K. Romanidis, S. Kakolyris, G. Papashinopoulos, A. Rigas
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2014/160236
id doaj-f320d34bb5ab47ed9bc4ed84e6749505
record_format Article
spelling doaj-f320d34bb5ab47ed9bc4ed84e67495052020-11-24T22:55:56ZengHindawi LimitedInternational Journal of Genomics2314-436X2314-43782014-01-01201410.1155/2014/160236160236γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung CancerE. Chatzimichail0D. Matthaios1D. Bouros2P. Karakitsos3K. Romanidis4S. Kakolyris5G. Papashinopoulos6A. Rigas7Department of Electrical and Computer Engineering, Democritus University of Thrace, Xanthi, GreeceDepartment of Oncology, Democritus University of Thrace, Alexandroupolis, GreeceDepartment of Pneumonology, Democritus University of Thrace, Alexandroupolis, GreeceDepartment of Cytopathology, University of Athens Medical School, “Attikon” University Hospital, Athens, Greece2nd Department of Surgery, Democritus University of Thrace, Alexandroupolis, GreeceDepartment of Oncology, Democritus University of Thrace, Alexandroupolis, GreeceDepartment of Electrical and Computer Engineering, Democritus University of Thrace, Xanthi, GreeceDepartment of Electrical and Computer Engineering, Democritus University of Thrace, Xanthi, GreeceCancer is a leading cause of death worldwide and the prognostic evaluation of cancer patients is of great importance in medical care. The use of artificial neural networks in prediction problems is well established in human medical literature. The aim of the current study was to assess the prognostic value of a series of clinical and molecular variables with the addition of γ-H2AX—a new DNA damage response marker—for the prediction of prognosis in patients with early operable non-small cell lung cancer by comparing the γ-H2AX-based artificial network prediction model with the corresponding LR one. Two prognostic models of 96 patients with 27 input variables were constructed by using the parameter-increasing method in order to compare the predictive accuracy of neural network and logistic regression models. The quality of the models was evaluated by an independent validation data set of 11 patients. Neural networks outperformed logistic regression in predicting the patient’s outcome according to the experimental results. To assess the importance of the two factors p53 and γ-H2AX, models without these two variables were also constructed. JR and accuracy of these models were lower than those of the models using all input variables, suggesting that these biological markers are very important for optimal performance of the models. This study indicates that neural networks may represent a potentially more useful decision support tool than conventional statistical methods for predicting the outcome of patients with non-small cell lung cancer and that some molecular markers, such as γ-H2AX, enhance their predictive ability.http://dx.doi.org/10.1155/2014/160236
collection DOAJ
language English
format Article
sources DOAJ
author E. Chatzimichail
D. Matthaios
D. Bouros
P. Karakitsos
K. Romanidis
S. Kakolyris
G. Papashinopoulos
A. Rigas
spellingShingle E. Chatzimichail
D. Matthaios
D. Bouros
P. Karakitsos
K. Romanidis
S. Kakolyris
G. Papashinopoulos
A. Rigas
γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
International Journal of Genomics
author_facet E. Chatzimichail
D. Matthaios
D. Bouros
P. Karakitsos
K. Romanidis
S. Kakolyris
G. Papashinopoulos
A. Rigas
author_sort E. Chatzimichail
title γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
title_short γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
title_full γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
title_fullStr γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
title_full_unstemmed γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
title_sort γ-h2ax: a novel prognostic marker in a prognosis prediction model of patients with early operable non-small cell lung cancer
publisher Hindawi Limited
series International Journal of Genomics
issn 2314-436X
2314-4378
publishDate 2014-01-01
description Cancer is a leading cause of death worldwide and the prognostic evaluation of cancer patients is of great importance in medical care. The use of artificial neural networks in prediction problems is well established in human medical literature. The aim of the current study was to assess the prognostic value of a series of clinical and molecular variables with the addition of γ-H2AX—a new DNA damage response marker—for the prediction of prognosis in patients with early operable non-small cell lung cancer by comparing the γ-H2AX-based artificial network prediction model with the corresponding LR one. Two prognostic models of 96 patients with 27 input variables were constructed by using the parameter-increasing method in order to compare the predictive accuracy of neural network and logistic regression models. The quality of the models was evaluated by an independent validation data set of 11 patients. Neural networks outperformed logistic regression in predicting the patient’s outcome according to the experimental results. To assess the importance of the two factors p53 and γ-H2AX, models without these two variables were also constructed. JR and accuracy of these models were lower than those of the models using all input variables, suggesting that these biological markers are very important for optimal performance of the models. This study indicates that neural networks may represent a potentially more useful decision support tool than conventional statistical methods for predicting the outcome of patients with non-small cell lung cancer and that some molecular markers, such as γ-H2AX, enhance their predictive ability.
url http://dx.doi.org/10.1155/2014/160236
work_keys_str_mv AT echatzimichail gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT dmatthaios gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT dbouros gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT pkarakitsos gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT kromanidis gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT skakolyris gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT gpapashinopoulos gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
AT arigas gh2axanovelprognosticmarkerinaprognosispredictionmodelofpatientswithearlyoperablenonsmallcelllungcancer
_version_ 1725655697899651072